{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/saps",
      "@type": "sc:SoftwareApplication",
      "sc:additionalType": "Command-line tool",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0634"
        },
        {
          "@id": "edam:topic_3053"
        },
        {
          "@id": "edam:topic_2269"
        }
      ],
      "sc:author": [
        "cre]",
        "Daniel Schmolze [aut",
        "Benjamin Haibe-Kains [aut]",
        "Andrew Beck [aut]"
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1371/journal.pcbi.1002875"
      },
      "sc:description": "Functions implementing the Significance Analysis of Prognostic Signatures method that provides a robust method for identifying biologically significant gene sets associated with patient survival. Three basic statistics are computed: P_pure, P_random and a pre-ranked Gene Set Enrichment Analysis (GSEA). A score is calculated to summarize the three statistics, and optionally a Q-value is computed to estimate the significance.",
      "sc:featureList": {
        "@id": "edam:operation_3224"
      },
      "sc:name": "saps",
      "sc:provider": "BioConductor",
      "sc:url": "https://www.bioconductor.org/packages/3.2/bioc/html/saps.html",
      "sc:version": "2.2.0"
    },
    {
      "@id": "https://doi.org/10.1371/journal.pcbi.1002875",
      "@type": "sc:CreativeWork"
    }
  ]
}